Bullboard - Stock Discussion Forum Regenxbio Inc RGNX

Healthcare Biotechnology

REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three... see more

Add To Watchlist

NDAQ:RGNX - Post Discussion

Regenxbio Inc > RegenxBio Inc: A Compelling Investment Opportunity!

View:

Post by AviseAnalytics on Aug 10, 2021 8:55am

RegenxBio Inc: A Compelling Investment Opportunity!

Excited to share an article on RegenxBio, Inc (NASDAQ: RGNX), a leader in gene therapy , whose NAV technology platform is behind Zolgensma, Novartis's drug intended for the treatment of Spinal Muscular Dystrophy.

Multiple Strategic Collaboration with industry leading pharmaceutical companies, a robust patent portfolio, a very promising pipeline and experienced management team make this company a must watch in our list!

Read on to find out more!

[url=https://www.aviseanalytics.com/regenxbio-inc-a-compelling-investment-opportunity/]Learn More[/url]

https://www.aviseanalytics.com/regenxbio-inc-a-compelling-investment-opportunity/